An economic evaluation of manic-depressive illness : 1991.
In 1991, the costs for manic-depressive illness, which has a lifetime prevalence of 1.3% among adult Americans, totaled $45 billion.
Costs were broken down into their direct and indirect components.
Direct costs totaling $7 billion consist of expenditures for inpatient and outpatient care, which are treatment related, as well as nontreatment-related expenditures such as those for the criminal justice system used by individuals with manic-depressive illness.
Indirect costs, which were $38 billion, include the lost productivity of both wage-earners ($17 billion) and homemakers ($3 billion), individuals who are in institutions ($3 billion) or who have committed suicide ($8 billion), and caregivers who take care of manic-depressive family members ($6 billion).
The method for determining each expenditure is provided, and the implications of these staggering costs are discussed.
These calculations rely heavily on methods and data bases that were developed for the accompanying paper on the costs of schizophrenia.
Mots-clés Pascal : Trouble bipolaire, Trouble humeur, Analyse coût, Economie santé, Etats Unis, Amérique du Nord, Amérique, Homme, Santé mentale, Coût indirect, Coût direct
Mots-clés Pascal anglais : Bipolar disorder, Mood disorder, Cost analysis, Health economy, United States, North America, America, Human, Mental health
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0487425
Code Inist : 002B18H05B. Création : 01/03/1996.